Literature DB >> 8097440

Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene.

M E Steinhelper1.   

Abstract

The structure of the mouse natriuretic peptide type-B (BNP) gene was determined by isolating and sequencing genomic clones. The mouse BNP gene was structurally similar to other natriuretic peptide genes and comprised three exons and two introns. Expression of the mouse BNP gene was found only in cardiac tissue as determined by ribonuclease protection analyses. Initiation of transcription was 31 bp downstream from a consensus TATA box as determined by primer extension analysis of cardiac RNA. Comparative DNA sequence analysis identified several DNA elements with potential transcriptional regulatory function. Comparative amino acid sequence analysis showed that the N-terminal portion of the mouse and rat BNP precursors was more conserved than the C-terminal 45-amino-acid sequence that constitute the bioactive BNP-45 peptide. The proteolytic processing site (RXXR-S) generating bioactive BNPs was highly conserved among all BNP precursors and was identical to the consensus site of furin, a calcium-dependent serine endoprotease. Finally, the BNP gene was mapped using recombinant inbred DNA and a polymerase chain reaction-based restriction fragment-length polymorphism assay to mouse chromosome 4 near the atrial natriuretic factor (Anf) locus. No recombination event between Bnp and Anf was evident in the 39 recombinant inbred and inbred strains examined. This physical linkage between the two natriuretic peptide genes expressed in cardiac tissue may be important for their transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097440     DOI: 10.1161/01.res.72.5.984

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.

Authors:  Jason M Tonne; Jarryd M Campbell; Alessandro Cataliotti; Seiga Ohmine; Tayaramma Thatava; Toshie Sakuma; Fima Macheret; Brenda K Huntley; John C Burnett; Yasuhiro Ikeda
Journal:  Clin Chem       Date:  2011-04-11       Impact factor: 8.327

2.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

3.  Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; N Tamura; S Suga; T Yoshimasa; M Uehira; S Matsuda; S Shiono; H Nishimoto; K Nakao
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Characterization of the 5'-flanking region and chromosomal assignment of the human brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; O Nakagawa; G Shirakami; N Tamura; T Yoshimasa; K Nagata; N Yoshida; K Nakao
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

5.  Expression and differential regulation of natriuretic peptides in mouse macrophages.

Authors:  A M Vollmar; R Schulz
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Involvement of natriuretic peptide system in C2C12 myocytes.

Authors:  Kiyoshi Ishikawa; Taiki Hara; Kana Kato; Takeshi Shimomura; Kenji Omori
Journal:  Mol Cell Biochem       Date:  2018-12-05       Impact factor: 3.396

7.  The heart as an endocrine organ.

Authors:  Tsuneo Ogawa; Adolfo J de Bold
Journal:  Endocr Connect       Date:  2014-04-15       Impact factor: 3.335

8.  The virtually mature B-type natriuretic peptide (BNP1-32) is a precursor for the more effective BNP1-30.

Authors:  Anja Schwiebs; Yong Wang; Andrew M Moore; Xudong Zhu; Kristin Pankow; Wolf-Eberhard Siems; Thomas Walther
Journal:  Br J Pharmacol       Date:  2020-02-19       Impact factor: 8.739

Review 9.  NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and Beyond.

Authors:  Hideaki Inazumi; Koichiro Kuwahara
Journal:  Biology (Basel)       Date:  2022-08-10

10.  Crosstalk between cardiomyocytes and noncardiomyocytes is essential to prevent cardiomyocyte apoptosis induced by proteasome inhibition.

Authors:  Fang Guo; Chen-Chen Zhang; Xi-Hui Yin; Ting Li; Cheng-Hu Fang; Xi-Biao He
Journal:  Cell Death Dis       Date:  2020-09-19       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.